Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 255 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Immune interception represents an exciting opportunity to stop cancer in its... September 16, 2025 A tribute to Professor Anne Charlton June 23, 2020 2-Time Cancer Survivor Warns Against Breast Implants After 4 Doctors Missed... June 25, 2019 Opinion: What should the cancer agenda look like for the new... September 22, 2022 Load more HOT NEWS EMA Recommends Extension of Therapeutic Indications for Tislelizumab Adolescent and Young Adult Cancer Survivors Face More Co-morbidity in Later... Prognostic Value of Longitudinal ctDNA Assessment in Oesophageal Cancer Artificial Intelligence Brings Pancreatic Cancer Screening One Step Closer to Reality...
